Related Experiment Videos
Does preoperatively administered parecoxib prevent succinylcholine-associated myalgia? A randomized,
J-U Schreiber1, T Mencke, S Pradarutti
1University Hospital of the Saarland, Department of Anaesthesia and Critical Care Medicine, Homburg, Germany. jan.schreiber@uniklinik-saarland.de
European Journal of Anaesthesiology
|January 28, 2006
Summary
Preoperative administration of parecoxib did not significantly reduce the incidence or severity of postoperative succinycholine-related myalgia. This selective cyclooxygenase 2 inhibitor did not improve patient activity limitations.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Non-selective cyclooxygenase inhibitors like aspirin may reduce postoperative succinycholine-related myalgia.
- The efficacy of selective cyclooxygenase 2 inhibitors for this indication is less understood.
Purpose of the Study:
- To evaluate the effect of preoperatively administered parecoxib on postoperative myalgia.
- To assess the impact of parecoxib on the severity and incidence of myalgia and patient activity.
Main Methods:
- A double-blind, randomized study involving 68 patients.
- Patients received either parecoxib 40 mg intravenously or saline before anesthesia induction.
- Myalgia incidence, severity, and activity limitations were assessed using a standardized questionnaire at 24, 48, and 72 hours post-anesthesia.
Main Results:
- Myalgia was reported by 7 patients in the parecoxib group versus 11 in the control group (not statistically significant).
- No significant differences were observed in myalgia severity or activity limitations between the parecoxib and control groups.
Conclusions:
- Intravenous parecoxib 40 mg administered preoperatively does not effectively reduce the incidence or severity of postoperative myalgia.
- Parecoxib did not demonstrate a benefit in improving the activity of patients experiencing myalgia.